4
Changes in Ownership
RxSight, Inc. Filed Acc 0000950170-24-010565
Chief Operating Officer sold 7,129 shares at an average $49.29 ($351,411)
- Chief Operating Officer acquired 7,129 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Goldshleger Ilya Chief Operating Officer | 2024-02-01 | Option exercise 10b5-1 | +6,539 | $18.90 | $123,587 | 33,014 | D |
| Goldshleger Ilya Chief Operating Officer | 2024-02-01 | Option exercise 10b5-1 | +590 | $23.04 | $13,594 | 33,604 | D |
| Goldshleger Ilya Chief Operating Officer | 2024-02-01 | Sale 10b5-1 | −3,539 | $49.00 | $173,411 | 30,065 | D |
| Goldshleger Ilya Chief Operating Officer | 2024-02-01 | Sale 10b5-1 | −3,000 | $49.50 | $148,500 | 27,065 | D |
| Goldshleger Ilya Chief Operating Officer | 2024-02-01 | Sale 10b5-1 | −590 | $50.00 | $29,500 | 26,475 | D |
| Derivatives | |||||||
| Goldshleger Ilya Chief Operating Officer | 2024-02-01 | Option exercise · Stock Option (right to buy) 10b5-1 | −6,539 | 7,981 | D | ||
| Goldshleger Ilya Chief Operating Officer | 2024-02-01 | Option exercise · Stock Option (right to buy) 10b5-1 | −590 | 30,000 | D | ||
| Open-market sales · 7,129 sh · avg $49.29 · $351,411 | |||||||
Loading xslF345X05/ownership.xml…